SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8
http://www.w3.org/2000/01/rdf-schema#comment
"A single intravenous injection of adeno-associated virus 2/8 or AAVrh10 expressing PCCA into propionic academia hypomorphic mice decreased systemic propionylcarnitine and methyl citrate for up to 1.5 years."
xsd:string
http://purl.uniprot.org/uniprot/#_EE395E7C31C7BB244CA01D747BD193339F0E1EA7B186F098AAD3F0A0C31D9348BEF600D6726C94802BB34E58338BD832
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8
http://purl.uniprot.org/uniprot/Q91ZA3
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8
http://purl.uniprot.org/uniprot/#_Q91ZA3-mappedCitation-25654275
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0CE555962E4B7D16B9B9A5D5CC333D8690C13F5DC4C6F37DD580459E7C73A552268C686E44F08E694584D4B8E93C4AB8